Hypergonadotropic hypogonadism, SHBG deficiency and hyperprolactinaemia: a transient phenomenon during induction chemotherapy in leukemic children.
D000328:Adult; D001215:Asparaginase / Q000009:adverse effects*; D002675:Child, Preschool; D003630:Daunorubicin / Q000009:adverse effects*; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007006:Hypogonadism / Q000139:chemically induced*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011241:Prednisone / Q000009:adverse effects*; D011388:Prolactin / Q000097:blood*; D012738:Sex Hormone-Binding Globulin / Q000172:deficiency*; D013739:Testosterone / Q000097:blood; D014750:Vincristine / Q000009:adverse effects*
D012738:Sex Hormone-Binding Globulin; D013739:Testosterone; D004958:Estradiol; D014750:Vincristine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin